http://arthritis-infos.com Arthritis Types, Joint Pain, Arthritis Cause Sun, 11 Apr 2010 20:39:49 +0000 http://wordpress.org/?v=2.8.5 en hourly 1 http://arthritis-infos.com/new-arthritis-drug-fares-well-in-trials.html http://arthritis-infos.com/new-arthritis-drug-fares-well-in-trials.html#comments Sat, 21 Jun 2008 04:55:01 +0000 Thomas Nowann http://arthritis-infos.com/new-arthritis-drug-fares-well-in-trials.html Article by Freddic  A novel pharmaceutical drug for the treatment of rheumatoid arthritis (RA) has been found to be both safe and effective in its late Stage III trials. The drug is reportedly being developed by Johnson & Jonson and Schering-Plough. Golimumab, the drug being tested is an immunosuppressive drug that targets tumor necrosis factor alpha (TNF-alpha), which is a pro-inflammatory molecule. Objectives Met During Trials During the first two trial the anti-TNF medicine was successful in reducing symptoms of (RA) by at least 20 percent, which was also the main objective of the tria Click to read more

]]> Article by Freddic  A novel pharmaceutical drug for the treatment of rheumatoid arthritis (RA) has been found to be both safe and effective in its late Stage III trials. The drug is reportedly being developed by Johnson & Jonson and Schering-Plough. Golimumab, the drug being tested is an immunosuppressive drug that targets tumor necrosis factor alpha (TNF-alpha), which is a pro-inflammatory molecule. Objectives Met During Trials During the first two trial the anti-TNF medicine was successful in reducing symptoms of (RA) by at least 20 percent, which was also the main objective of the tria Click to read more

]]> http://arthritis-infos.com/new-arthritis-drug-fares-well-in-trials.html/feed 0